Home   Chapter Home   Jobs   Conferences   Fellowships   Books




Intrinsic pathway

Reviewer: Jeremy Parsons, M.D. (see Reviewers page)
Revised: 9 June 2012, last major update June 2012
Copyright: (c) 2002-2012, PathologyOutlines.com, Inc.


● Involves factors VIII, IX, XI, XII (Hageman factor), prekallikrein, high molecular weight kininogen (Wikipedia)
● Merges with extrinsic pathway into common pathway
● Activated when factor XII binds to negatively charged “foreign” surface exposed to blood
● Then sequentially activates factors XI, IX, X, then factor II (prothrombin to thrombin), which converts fibrinogen to fibrin (see common pathway)
● Once extrinsic pathway is inhibited by TFPI-Xa complex (see extrinsic pathway), factor VIIIa / IXa complex becomes dominant generator of factor Xa, thrombin and fibrin
● Factor XIIa also converts prekallikrein to kallikrein, which activates more factor XIIa; both require high molecular weight kininogen as cofactors
● Kallikrein also releases bradykinin from high molecular weight kininogen, which causes vasoconstriction
● The activated partial thromboplastin time (aPTT) measures the intrinsic and common pathways


Intrinsic pathway

Additional references

● Kolde, Hans-Jurgen (2004). Haemostasis. Basel, Switzerland: Pentapharm Ltd.

End of Coagulation > General > Intrinsic pathway

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.

All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).